The VeriLumen^TM CRP+SAA Rapid Test is an in vitro fluorescence immunochromatographic assay for the quantitative detection of C-reactive protein (CRP) and serum amyloid A (SAA) in human whole blood, plasma, or serum. CRP and SAA are acute-phase proteins that increase in response to inflammation, with CRP widely used as a general marker of infection and inflammatory activity, and SAA serving as a more sensitive and rapidly responsive indicator of inflammation and tissue injury. The assay provides rapid quantitative results to support clinical evaluation in point-of-care and laboratory settings.

This combined test may assist healthcare professionals in the assessment and monitoring of inflammatory and infectious conditions, including bacterial infections and systemic inflammatory responses, as well as in supporting evaluation of disease progression and treatment response. CRP measurement may additionally support cardiovascular risk assessment when interpreted alongside other clinical and laboratory findings. Results should be evaluated in conjunction with clinical information and other diagnostic data.